As a functional medicine doctor, my approach to health emphasizes addressing root causes, optimizing the body’s natural resilience, and empowering patients to make informed decisions based on their unique biology and circumstances. The recent preprint study from the Cleveland Clinic, titled “Effectiveness of the Influenza Vaccine During the 2024-2025 Respiratory Viral Season,” has sparked significant discussion due to its unexpected findings: the influenza vaccine not only failed to protect a large cohort of working-age healthcare employees but was associated with a 27% higher risk of contracting the flu. From a functional medicine perspective, this study is profoundly important—not because it definitively proves vaccines are harmful, but because it raises critical questions about assumptions, policies, and the one-size-fits-all approach to health interventions. Let’s unpack why this study matters, focusing on its implications for individualized care, immune system dynamics, and the broader conversation about public health strategies.
A Paradigm-Shifting Finding
The Cleveland Clinic study followed 53,402 employees in Ohio over a 25-week period starting October 1, 2024. Of these, 82.1% (43,857 individuals) received the trivalent inactivated influenza vaccine, while 1,079 employees (2.02%) contracted laboratory-confirmed influenza. Using Cox proportional hazards regression—a robust statistical method that accounts for time-dependent variables—the researchers found that vaccinated individuals had a hazard ratio (HR) of 1.27 (95% CI: 1.07–1.51, P=0.007), translating to a 27% increased risk of flu compared to their unvaccinated counterparts. This yielded a vaccine effectiveness (VE) of -26.9% (95% CI: -51.0% to -6.6%), a statistically significant negative effectiveness.
For functional medicine practitioners, this finding is a clarion call to pause and reflect. We’re trained to question interventions that don’t align with observable outcomes, especially when they contradict prevailing narratives. The idea that a vaccine could be associated with increased infection risk challenges the assumption that annual flu shots are universally beneficial. It invites us to dig deeper into why this might have happened and what it means for our patients.
The Study’s Strengths: A Functional Medicine Lens
One of the study’s greatest strengths, from a functional medicine perspective, is its design. Unlike the more common “test-negative” studies, which estimate vaccine effectiveness based on odds ratios and can overestimate benefits, this prospective cohort study calculated actual risk. It treated vaccination status as a time-dependent variable, meaning it accounted for when individuals received the vaccine during the season. This methodological rigor aligns with functional medicine’s emphasis on precision and real-world evidence over generalized assumptions.
The large sample size—over 53,000 participants—also lends credibility. In functional medicine, we value data that reflects real-world populations, as it helps us tailor recommendations to diverse individuals. The fact that the study focused on healthcare workers, a group often exposed to influenza, makes the findings particularly relevant for understanding how interventions perform under high-exposure conditions.
Limitations and Context: Avoiding Overgeneralization
That said, the study has limitations that we must consider thoughtfully. It focused on a relatively healthy, working-age population, which doesn’t reflect the elderly, children, or immunocompromised individuals—groups often prioritized for flu vaccination. It also examined only the trivalent inactivated vaccine, leaving questions about other formulations, like quadrivalent or live-attenuated vaccines. Additionally, the study didn’t assess flu severity, hospitalizations, or mortality, so we can’t conclude whether the vaccine influenced those outcomes.
From a functional medicine standpoint, these limitations underscore the importance of context. We don’t treat populations; we treat individuals. A study showing negative effectiveness in one group doesn’t mean the vaccine is universally ineffective or harmful. Instead, it highlights the need to ask: Why did this happen in this population? Was it the vaccine formulation, the circulating flu strains, or something about the immune response in this cohort? These questions align with our focus on root causes and personalized care.
Immune System Dynamics: A Functional Medicine Inquiry
The finding of negative vaccine effectiveness raises intriguing questions about immune system dynamics—an area central to functional medicine. One possibility is that the 2024-2025 vaccine was poorly matched to the circulating influenza strains. Flu vaccines are developed months in advance, based on predictions about which strains will dominate. If the vaccine targeted strains that didn’t match the season’s viruses, it could fail to confer protection. But why an increased risk of infection?
Functional medicine encourages us to explore mechanisms like immune imprinting or interference. Immune imprinting occurs when prior exposures (via infection or vaccination) shape how the immune system responds to new challenges, sometimes limiting its flexibility. If the vaccine primed the immune system to recognize outdated strains, it might have left vaccinated individuals less equipped to fight the season’s dominant viruses. Another hypothesis is vaccine-induced immune suppression, where certain components—like adjuvants or preservatives such as thimerosal—might subtly alter immune function in ways that increase susceptibility to infection. A 2012 study by Cowling et al. found that children receiving inactivated flu vaccines had a higher risk of non-influenza respiratory infections, suggesting vaccines can sometimes disrupt broader immune balance.
We also consider the role of baseline health. Healthcare workers are often under stress, exposed to pathogens, and may have varying levels of nutritional status or sleep quality—all factors that influence immune resilience. In functional medicine, we assess these variables holistically. If vaccinated individuals had different health profiles (e.g., higher stress or lower vitamin D levels), this could confound the results. The study adjusted for age, sex, job role, and location, but not for lifestyle factors, which we know are critical.
Challenging Assumptions About Annual Vaccination
The Cleveland Clinic study also prompts a broader discussion about annual flu vaccination policies, particularly mandates. Many healthcare systems, including Cleveland Clinic, require employees to either get vaccinated or seek exemptions. The study’s authors note that such policies assume consistent efficacy, yet their data suggest otherwise for 2024-2025. From a functional medicine perspective, this is a critical point. Mandates imply a one-size-fits-all benefit, but health is never that simple.
We advocate for informed choice, where patients weigh risks and benefits based on their unique circumstances. For some, a flu vaccine might reduce risk or align with their preferences. For others, especially healthy adults with robust immune systems, the benefit may be unclear—particularly if the vaccine underperforms. The study’s negative effectiveness finding strengthens the case for pausing mandates until real-time data confirms a vaccine’s value each season. It also highlights the ethical importance of transparency: patients and employees deserve to know when an intervention might not deliver as promised.
Implications for Public Health Policy
Public health strategies often prioritize population-level interventions, but functional medicine focuses on the individual within the population. The Cleveland Clinic study suggests a need for more nuanced policies. For example, instead of blanket recommendations, we could prioritize high-risk groups while encouraging healthy adults to optimize their immunity through nutrition, stress management, and sleep. The study’s authors call for rigorous, real-time evaluations of vaccine performance, a proposal that resonates with our demand for evidence-based practice.
This also ties into the concept of “vaccine fatigue.” When interventions are promoted as essential but fail to deliver, trust erodes. Functional medicine emphasizes building trust through education and empowerment. If vaccines are to remain a cornerstone of public health, their performance must be scrutinized annually, and findings like these must be openly discussed—not dismissed. The study’s preprint status (not yet peer-reviewed) doesn’t diminish its value; it’s a starting point for dialogue, not a final verdict.
A Holistic Approach to Flu Prevention
The study’s findings reinforce the functional medicine principle that no single intervention—vaccine or otherwise—can replace a holistic approach to health. While vaccines aim to prime the immune system, they’re one tool among many. We emphasize strengthening immunity through:
- Nutrition: Diets rich in vitamin C, zinc, and antioxidants (e.g., berries, leafy greens) support immune function. Vitamin D, often deficient in winter, is critical for antiviral defenses.
- Lifestyle: Adequate sleep, regular exercise, and stress reduction (via meditation or yoga) bolster resilience. Chronic stress suppresses immunity, potentially amplifying infection risk.
- Gut Health: The gut houses 70% of the immune system. Probiotics, prebiotics, and fermented foods enhance microbial balance, which may influence responses to pathogens or vaccines.
- Supplements: Targeted support, like elderberry or N-acetylcysteine, can modulate immune responses, though individual needs vary.
These strategies don’t preclude vaccines but complement them. If a vaccine’s effectiveness is questionable, as this study suggests, patients can lean on these pillars to reduce risk naturally. For healthcare workers, who face high exposure, optimizing these factors could be as critical as any shot.
The Role of Informed Consent
In functional medicine, informed consent is sacred. Patients deserve clear, unbiased information about interventions, including potential risks. The Cleveland Clinic study highlights a gap in this process. If a vaccine is associated with increased infection risk, even in one season, that information must be shared transparently—not buried under assurances of general safety. This is especially true for mandated vaccines, where choice is limited.
The study’s negative effectiveness (-26.9%) doesn’t mean the vaccine caused flu, but it suggests it didn’t protect as intended and may have altered immune dynamics in unexpected ways. Patients should know this when deciding whether to vaccinate, alongside data on severity or other outcomes. Functional medicine empowers patients to ask: Does this align with my health goals? For some, the answer may be no, and that’s valid.
Moving Forward: Questions and Research Needs
The Cleveland Clinic study opens a Pandora’s box of questions that functional medicine is uniquely positioned to explore:
- Mechanistic Studies: Why did vaccinated individuals have higher infection rates? Was it strain mismatch, immune imprinting, or something else? Research into vaccine components (e.g., thimerosal, adjuvants) and their immune effects is overdue.
- Individual Variability: How do genetics, epigenetics, or microbiome differences influence vaccine outcomes? Functional medicine’s focus on personalized testing (e.g., nutrient levels, gut health) could guide tailored recommendations.
- Long-Term Impacts: Does annual vaccination alter immune function over time? We need longitudinal studies to assess cumulative effects, especially in high-exposure groups like healthcare workers.
- Alternative Metrics: The study didn’t measure severity or hospitalizations. Future research should explore whether vaccines reduce complications, even if they don’t prevent infection.
These questions don’t negate vaccines’ potential but demand a deeper understanding of their role in complex immune systems. Functional medicine thrives on this complexity, seeking answers that honor individual differences.
A Wake-Up Call for Trust and Transparency
Ultimately, the Cleveland Clinic study is important because it shakes complacency. It reminds us that health interventions, no matter how entrenched, must be scrutinized continually. For functional medicine doctors, it’s a validation of our skepticism toward one-size-fits-all solutions and our commitment to evidence that serves the individual.
This study also underscores the fragility of trust in healthcare. When outcomes defy expectations, dismissing them risks alienating patients. Instead, we must engage openly, acknowledging uncertainty and prioritizing truth over dogma. Functional medicine offers a path forward: listen to patients, investigate anomalies, and build health from the ground up.
In conclusion, the Cleveland Clinic’s findings aren’t a condemnation of flu vaccines but a call to rethink assumptions, refine strategies, and respect individual choice. As functional medicine practitioners, we see this as an opportunity to advocate for personalized care, robust immune health, and a healthcare system that earns trust through transparency. By embracing these principles, we can navigate the complexities of modern medicine while keeping patients at the heart of every decision.
REFERENCES
- Shrestha NK, Burke PC, Nowacki AS, Gordon SM. Effectiveness of the Influenza Vaccine During the 2024-2025 Respiratory Viral Season. medRxiv. Posted April 4, 2025. https://doi.org/10.1101/2025.01.30.25321421
- Cowling BJ, et al. Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine. Clin Infect Dis. 2012;54(12):1778-1783.